Okay. So, Sarkis, you may recall that in Q1, when we think about our initial projects and prospects for this year, it was around 9% of revenue, which is fairly high due to some substantial projects. As we are going to finish, as Bill indicated, between 15% to 17%, it takes us to a more normalized level of a 5% revenue, where the company, in a normalized time, should run between 4% to 5% CapEx, 4% to 4.5% CapEx. The fact that the COVID effect has pushed out many of the automation projects for precision -- I mean, okay, let me take a step back. One of the major projects was advanced sensors and this -- the infrastructure and the capacity to support 30%, 40% higher capacity, and this has been completed. The next step would be in order to -- once we reach the capacity limitation to increase advanced sensors capacity, in addition to that, there was a big part in the original plan in 2021 of precision resistors automation in order to reduce the cost base. Unfortunately, much of those projects were pushed out due to the fact that during COVID, we were not able to get our vendors to travel and lead times for the equipment manufacturing has been extended significantly. So I would say that, all in all, the 9% that initially we have been planning to invest this year, which all of them has very good return on investment, probably will be pushed out into 2022 as we are in the process of getting this equipment being installed. And now since the situation has been, in a way, improved in the United States, and to some extent, in Europe, we are able to get vendors installing the equipment and getting those equipment fully operational. So this is a gear shift from 4.5%, 5% this year CapEx of revenue into the 9% next year?